Literature DB >> 10379728

Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder.

M B Chancellor1, W C de Groat.   

Abstract

PURPOSE: Pharmacological treatment of the overactive bladder relies on partially blocking the efferent parasympathetic innervation to the detrusor with anticholinergic drugs. However, often these drugs have troublesome side effects and doses are insufficient to restore continence in patients with detrusor instability. We present the background, basic and clinical research with intravesical instillation of capsaicin and resiniferatoxin as treatments for the overactive bladder.
MATERIALS AND METHODS: Capsaicin, the main pungent ingredient in hot peppers of the genus Capsicum, is a specific neurotoxin that desensitizes C fiber afferent neurons which may be responsible for signals that trigger detrusor overactivity.
RESULTS: In the last 6 years studies have demonstrated encouraging improvement in lower urinary tract symptoms with minimal long-term complications. Most of these studies have also demonstrated that the acute pain and irritation associated with capsaicin are major deterrents to widespread use. Therefore, resiniferatoxin, an ultra-potent analogue of capsaicin which appears to have similar efficacy but less acute side effects, may be more useful.
CONCLUSIONS: Intravesical capsaicin and resiniferatoxin are novel and promising treatments for the overactive bladder, with profound basic and clinical implications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379728     DOI: 10.1097/00005392-199907000-00002

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  55 in total

1.  [New pharmacological treatment concepts for overactive bladder].

Authors:  M C Michel
Journal:  Urologe A       Date:  2003-04-25       Impact factor: 0.639

2.  Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats.

Authors:  Jeffrey A Larson; P Dafe Ogagan; Guoqing Chen; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

Review 3.  How does the urothelium affect bladder function in health and disease? ICI-RS 2011.

Authors:  L A Birder; M Ruggieri; M Takeda; G van Koeveringe; S Veltkamp; C Korstanje; B Parsons; C H Fry
Journal:  Neurourol Urodyn       Date:  2012-01-24       Impact factor: 2.696

4.  [100 years urology in Germany. Neuro-urology].

Authors:  J Pannek; P M Braun; W Diederichs; M Hohenfellner; K P Jünemann; H Madersbacher; A Reitz; S Schumacher; M Stöhrer
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 5.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

6.  Neurophysiology of lower urinary tract function and dysfunction.

Authors:  Naoki Yoshimura; Michael B Chancellor
Journal:  Rev Urol       Date:  2003

Review 7.  Spinal reflex control of micturition after spinal cord injury.

Authors:  Changfeng Tai; James R Roppolo; William C de Groat
Journal:  Restor Neurol Neurosci       Date:  2006       Impact factor: 2.406

Review 8.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

9.  Inhibitory and excitatory perigenital-to-bladder spinal reflexes in the cat.

Authors:  Changfeng Tai; Bing Shen; Jicheng Wang; Michael B Chancellor; James R Roppolo; William C de Groat
Journal:  Am J Physiol Renal Physiol       Date:  2007-12-26

Review 10.  Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.

Authors:  Hashim Hashim; Paul Abrams
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.